Bionano Genomics, Inc. (BNGO) — 10-Q Filings
All 10-Q filings from Bionano Genomics, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Bionano Genomics Narrows Losses, Faces Going Concern Doubt
— Nov 13, 2025 Risk: high
Bionano Genomics, Inc. reported a net loss of $8.5 million for the three months ended September 30, 2025, a significant improvement from the $44.2 million net l -
Bionano Genomics Narrows Losses Amid Revenue Dip, Going Concern Warning
— Aug 14, 2025 Risk: high
Bionano Genomics, Inc. (BNGO) reported a significant reduction in net loss for the six months ended June 30, 2025, decreasing to $9.96 million from $47.65 milli -
Bionano Genomics Files Q1 2025 10-Q
— May 14, 2025 Risk: medium
Bionano Genomics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quart -
Bionano Genomics Q3 2024 10-Q Filed
— Nov 14, 2024 Risk: medium
Bionano Genomics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported revenue for the three months ended September 30, 2024, and -
Bionano Genomics Reports Q2 2024 Financials
— Aug 7, 2024 Risk: medium
Bionano Genomics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported revenue from product sales and services, with specific figures f -
Bionano Genomics, Inc. Files Q1 2024 10-Q Report
— May 8, 2024 Risk: medium
Bionano Genomics, Inc. (BNGO) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Bionano Genomics, Inc. filed its Form 10-Q for the quarterly period e
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX